Cargando…

Cancer treatment with kinase inhibitors: what have we learnt from imatinib?

Over the past few years, a number of anticancer drugs have been developed that specifically target kinases known to be oncogenic. The leading drug in this area is imatinib mesylate, which targets ABL, KIT and PDGFR. It has been remarkably effective in the treatment of chronic myeloid leukaemia, alth...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, D M, Hughes, T P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395307/
https://www.ncbi.nlm.nih.gov/pubmed/14710199
http://dx.doi.org/10.1038/sj.bjc.6601507